Daniel Rhodes
Daniel Rhodes
University of Michigan, Compendia Bioscience, Life Technologies
Verified email at
Cited by
Cited by
The mutational constraint spectrum quantified from variation in 141,456 humans
KJ Karczewski, LC Francioli, G Tiao, BB Cummings, J Alföldi, Q Wang, ...
Nature 581 (7809), 434-443, 2020
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
ONCOMINE: a cancer microarray database and integrated data-mining platform
DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ...
Neoplasia 6 (1), 1-6, 2004
The mutational landscape of lethal castration-resistant prostate cancer
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...
Nature 487 (7406), 239-243, 2012
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ...
Neoplasia 9 (2), 166-180, 2007
Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes
KJ Karczewski, LC Francioli, G Tiao, BB Cummings, J Alföldi, Q Wang, ...
biorxiv, 531210, 2019
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ...
Proceedings of the National Academy of Sciences 101 (25), 9309-9314, 2004
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival
A Singh, P Greninger, D Rhodes, L Koopman, S Violette, N Bardeesy, ...
Cancer cell 15 (6), 489-500, 2009
Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer
DR Rhodes, TR Barrette, MA Rubin, D Ghosh, AM Chinnaiyan
Cancer research 62 (15), 4427-4433, 2002
Identification of targetable FGFR gene fusions in diverse cancers
YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ...
Cancer discovery 3 (6), 636-647, 2013
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ...
Cancer research 66 (7), 3396-3400, 2006
Probabilistic model of the human protein-protein interaction network
DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ...
Nature biotechnology 23 (8), 951-959, 2005
Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification
M Takahashi, DR Rhodes, KA Furge, H Kanayama, S Kagawa, BB Haab, ...
Proceedings of the National Academy of Sciences 98 (17), 9754-9759, 2001
Integrative analysis of the cancer transcriptome
DR Rhodes, AM Chinnaiyan
Nature genetics 37 (Suppl 6), S31-S37, 2005
Urine TMPRSS2: ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
SA Tomlins, SMJ Aubin, J Siddiqui, RJ Lonigro, L Sefton-Miller, S Miick, ...
Science translational medicine 3 (94), 94ra72-94ra72, 2011
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ...
Cancer research 67 (22), 10657-10663, 2007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
The system can't perform the operation now. Try again later.
Articles 1–20